Drugs / SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated
SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05172193 | Dec 2021 → Sep 2023 | COVID-19 | PT. Kimia Farma (Persero) Tbk | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05172193 ↗ |
| Modality | Vaccine | “SARS-CoV-2 vaccine (Vero cell) inactivated” NCT05172193 ↗ |
| Route | Intramuscular | “0.5 mL IM injection” NCT05172193 ↗ |